Komori
Kaneka (4118) · InitiativeFirst stated

EndoStream Medical Becomes a Consolidated Subsidiary; Launch of Cerebrovascular Treatment Products

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Launching cerebrovascular treatment products through the conversion of EndoStream Medical into a subsidiaryA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「The Israeli company EndoStream Medical, acquired through M&A, has begun launching new highly competitive products in the cerebrovascular treatment field and is expected to contribute to a full-scale expansion of its operations going forward.」

    This is the first disclosure that EndoStream Medical, which became a consolidated subsidiary in December 2024, has launched new products in the cerebrovascular treatment field and is expected to contribute to the Medical business.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kaneka yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.